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Abstract
Purpose—The purpose of this study is to summarize recent literature on approaches to
supporting healthy coping in diabetes, in two specific areas: 1) impact of different approaches to
diabetes treatment on healthy coping; and 2) effectiveness of interventions specifically designed to
support healthy coping.
Methods—A PubMed search identified 129 articles published August 1, 2006 – April 30, 2011,
addressing diabetes in relation to emotion, quality of life, depression, adjustment, anxiety, coping,
family therapy, behavior therapy, psychotherapy, problem-solving, couples therapy, or marital
therapy.
Results—Evidence suggests that treatment choice may significantly influence quality of life,
with treatment intensification in response to poor metabolic control often improving quality of
life. The recent literature provides support for a variety of healthy coping interventions in diverse
populations, including diabetes self-management education, support groups, problem-solving
approaches, and coping skills interventions for improving a range of outcomes, Cognitive
Behavior Therapy and collaborative care for treating depression, and family therapy for improving
coping in youths.
Conclusions—Healthy coping in diabetes has received substantial attention in the past five
years. A variety of approaches show positive results. Research is needed to compare effectiveness
of different approaches in different populations and determine how to overcome barriers to
intervention dissemination and implementation.
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In recognition of the wide range of coping challenges presented by diabetes across genetic,
behavioral, family, social, community, organizational, and political contexts, the American
Association of Diabetes Educators (AADE) has identified healthy coping as one of the key
AADE7™ Self-care Behaviors and defined it as the following:
“Health status and quality of life are affected by psychological and social factors.
Psychological distress directly affects health and indirectly influences a person’s motivation
to keep their diabetes in control. When motivation is dampened, the commitments required
for effective self-care are difficult to maintain. When barriers seem insurmountable, good
intentions alone cannot sustain the behavior. Coping becomes difficult and a person’s ability
to self-manage their diabetes deteriorates.”
From this definition, it is clear that the construct of “healthy coping” includes a number of
related but distinct domains of psychosocial outcomes. In addition to avoiding specific
psychological problems such as depressive and anxiety disorders, high levels of perceived
stress and other negative emotions, and diabetes-specific distress, healthy coping also
involves positive attitudes toward diabetes and its treatment, positive relationships with
others, and high perceived health-related quality of life (QOL). That is, healthy coping
extends beyond the mere avoidance of psychiatric morbidity to encompass high levels of
psychosocial functioning and a positive outlook on the illness and overall quality of life.
Table 1 provides more detail on specific healthy coping domains that are commonly
examined in the diabetes literature.
As awareness of the inter-relationships between diabetes, its management, and these
outcomes has grown, interest in intervening to facilitate healthy coping in diabetes patients
has also expanded. The purpose of this paper is to systematically review literature on healthy
coping in diabetes published in the past five years, with a focus on identifying evidence for
effective interventions that has emerged since a prior review 1. Two questions within this
broad topic area are addressed: 1) What are the effects of different diabetes treatment
approaches on healthy coping outcomes? 2) What is the effect of different interventions
designed to improve healthy coping on psychosocial and quality of life outcomes?
Methods
Search
Parallel with the multiple domains of healthy coping, intervention approaches for addressing
these concerns in diabetes patients across the lifespan are diverse, and there are relatively
few well-controlled studies of any single intervention approach. Thus, this review was
designed to provide a broad appraisal of promising approaches for addressing an array of
healthy coping issues. The review used systematic review procedures in specifying the terms
and approach to searching for and abstracting data from articles, but narrative procedures in
including articles without a priori criteria based on methods and design.
A PubMed search of the English-language literature published between August 1, 2006 and
April 30, 2011 was performed. Combinations of diabetes with the terms emotion, quality of
life, depression, adjustment, anxiety, anxious, coping, family therapy, behavior therapy,
psychotherapy, problem solving, couples therapy, or marital therapy were used to identify
relevant studies. Figure 1 provides details on search procedures and results.
Study Selection
Titles and abstracts of articles meeting the above search criteria were reviewed as candidates
for data abstraction. To be included in the final review, articles needed to report the effects
of either a diabetes treatment or healthy coping intervention on at least one psychosocial
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and/or quality of life outcome. Retrospective and prospective studies were included, along
with narrative or systematic review articles. All articles pertaining to T1DM or T2DM were
included and there were no restrictions with regard to patient age. Articles aimed at lay
audiences, statements of opinion, or descriptions of programs with no research component
were excluded.
Data Abstraction
Articles meeting criteria were grouped into the two main questions targeted for review: 1)
evidence describing the impact of diabetes treatments on healthy coping constructs; and 2)
interventions to promote healthy coping. Articles were then further categorized according to
intervention type (see Figure 1), abstracted independently by the authors, and incorporated
into the Healthy Coping Evidence Table (available as an online Appendix). Abstracted data
elements included study design, original research versus review of published studies, study
objectives, sample size, healthy coping outcomes assessed, other outcomes assessed (e.g.,
HbA1c), and principal findings, including both significant and non-significant results. For
all studies, the American Association of Clinical Endocrinologists’ (AACE) evidence
ratings2 corresponding to their study designs were also determined.
Study Characteristics
As shown in Figure 1, 129 articles met criteria for inclusion, including 59 articles examining
the effect of diabetes treatments on healthy coping domains and 70 articles examining the
efficacy or effectiveness of interventions specifically designed to promote healthy coping.
Cognitive behavior therapy, family therapy, diabetes self-management education, and
primary care-based approaches were the most common intervention types; fewer articles
were identified which focused on problem solving and coping skills, support groups or
group counseling, and medication for psychological problems.
Data Synthesis
The evidence table describing studies within the two broad areas relevant to healthy coping
in diabetes drove the organization of the narrative review accordingly: 1) effect of diabetes
treatments on QOL and psychosocial outcomes; 2) evidence for the efficacy or effectiveness
of healthy coping interventions in improving QOL and other psychosocial outcomes. Results
summarized in the text below focus on articles reporting original research, with Tables 2 and
3 providing additional detail in two areas. Table 2 summarizes the large number of studies
that examined the psychosocial and quality of life impacts of different methods of
intensifying treatment in poorly controlled diabetes, while Table 3 summarizes original
intervention research studies identified in the review. The complete Healthy Coping
Evidence Table is available as an online Appendix.
Results
Part 1: Impact of Diabetes Treatments on Quality of Life
A total of 45 original research studies and 14 review articles were identified that examined
psychosocial and QOL outcomes of different diabetes treatment approaches. One of the
most active areas of research suggests mostly, but not entirely,3 positive effects of
continuous subcutaneous insulin injection (CSII; i.e., insulin pump therapy) relative to
multiple daily injections (MDI) on treatment satisfaction, emotional health, and QOL in
youth with T1DM diabetes,4-9 their parents,5, 10-12 and adults with T1DM.13, 14 Although
only the Opipari-Arrigan study involving preschoolers with T1DM and their parents11 used
a randomized controlled design, the remaining observational studies have the advantage of
increased generalizability to real-world shared decision-making about treatments (i.e., for
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patients who elect to use the pump, coping and QOL tends to improve). Insulin pump use in
T2DM has been studied much less frequently. One study15 showed improved QOL and
treatment satisfaction in patients switching from injections to CSII, but no effect in patients
previously taking oral hypoglycemic agents (OHAs) only; another study16 reported no
overall QOL differences for CSII versus MDI. Other treatment advances such as inhaled
insulin,17, 18 continuous glucose monitoring,19-21 continuous intraperitoneal insulin
infusion,22 pancreatic-kidney23 and islet cell24 transplantation, and supplemental metformin
therapy25 in T1DM, have demonstrated positive QOL impacts, but small numbers of studies
and observational designs prohibit any firm conclusions.
Another active area has been how to intensify treatment in T2DM in a way that maximizes
QOL when initial lifestyle changes and OHAs fail to adequately control blood glucose. As
evidenced by studies listed in Table 126-33 – all of which consisted of randomized controlled
trials – treatment intensification in patients with poor glycemic control (e.g., >9.0%)
typically improves both QOL and treatment satisfaction. In addition, there appears to be
evidence of greater benefits when insulin or newer injectable agents (glucagon-like peptide
(GLP) agonists and analogues, amylin analogues) are added to the patient’s medication
regimen, versus adding another OHA (e.g., adding sitagliptin or pioglitazone to metformin
only). This research, along with studies documenting high prevalence of side effects
associated with OHAs,34, 35 suggest that insulin, and particularly insulin analogues,36-38 or
other injectable agents, may be preferred over complex OHA regimens in T2DM patients.
Part 2: Interventions to Promote Healthy Coping
Table 2 summarizes key original research studies published in the past five years that
evaluate interventions in terms of their effects on QOL and/or other psychosocial outcomes.
Several studies were identified that found diabetes self-management education to improve
QOL39-42 and other psychosocial and emotional outcomes, such as depressive symptoms43
and treatment satisfaction,42 although in some cases, beneficial healthy coping effects were
short-lived44 or not observed.45, 46 It is notable that of the five interventions in this category
demonstrating positive effects, four focused on self-managing insulin in conjunction with
diet for insulin-dependent and primarily T1DM patients.39-42 The only intervention targeted
at patients with T2DM showing positive effects focused on self-monitoring of blood glucose
and patient motivation, but did not employ a randomized, controlled design.43 This pattern
of results suggests that QOL and other psychosocial outcomes in T2DM may require more
intensive or coping-focused efforts beyond DSME.
Several studies suggested promising effects of adult patients’ participation in diabetes
support groups in diverse settings, including two well-designed, randomized, controlled
trials.47, 48 In the first trial, improved QOL in four domains (physical health,
psychological health, social participation, and environment) was observed among Thai
patients participating in a 16-week self-help group.47 In the second trial, improved
perceptions of social support and willingness to initiate insulin were observed among male
veterans participating in a reciprocal peer support program with supplemental group
sessions, although diabetes-related distress was not significantly different across groups.48
Finally, a small pilot study demonstrated improved activity and vigor levels in urban,
minority adults participating in peer-led community discussion circles, although did not
elicit significant changes in other aspects of well-being.49 The diversity of the patient
populations across these three studies suggest that the use of peer support may be a strategy
that is potentially robust across patient subgroups, at least among adults. However, the few
peer support studies identified overall, the lack of studies in youth with diabetes, and
heterogeneity in the specific psychosocial outcomes assessed highlight the need for more
research to understand the full potential of peer support in facilitating healthy coping.
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Recent studies also provide evidence for the efficacy of problem-solving and coping skills
interventions when delivered to adults with T2DM. A four-week problem-solving and
cognitive reframing telephone-based intervention for older African American women was
found to improve psychosocial adjustment and problem-solving, reduce uncertainty, and
increase participation in physical activity in one randomized controlled trial.50, 51 Another
intervention found that increasing one’s use of acceptance and mindfulness coping strategies
improved diabetes self-care.52 These studies suggest that an emphasis on problem-solving
may benefit psychosocial outcomes in addition to self-care behavior and glycemic control,
although more studies evaluating a common set of healthy coping outcomes are again
needed in this area as well.
There has been substantial interest in cognitive behavioral therapy (CBT), including several
studies suggesting effectiveness of CBT-based interventions on depressive symptoms and
diabetes-related stress, when delivered via novel formats, such as the internet and/or
telephone.53-55 However, evidence from recent trials is mixed, with some suggestion of less
favorable results when delivered to youth and/or youth-parent dyads54, 56 compared to
parents alone55 or adult patients.53, 57-59 In addition, one recent randomized trial of group
CBT suggests that CBT may be most helpful for patients who are experiencing higher
versus lower levels of depressive symptoms.57 A recent review of interventions for
individuals with diabetes and depression also noted the greatest improvements in depression
for CBT compared to other psychotherapeutic or pharmacological approaches.60
Several studies of family therapy approaches applied to youth with T1DM and their families
have produced good evidence of positive initial impacts on family conflict61, 62 and
interaction,63 adherence,62 and problem-solving63. The methodological quality of these
studies was high, with three of these four studies utilizing randomized, controlled designs
comparing family therapy to usual care and/or education support. No family therapy
interventions were identified for adults with either T1DM or T2DM, a major oversight in the
literature.
Additional evidence for the efficacy of sertraline in reducing depressive symptoms among
adult patients, as well as improving QOL and pain, was found in one randomized, double-
blind, controlled trial with low-income minority patients with diabetes and co-morbid
depression.64 However, another trial65 of the ability of sertraline to prevent recurrence of
major depressive disorder in diabetes patients achieving initial depression recovery found
evidence of efficacy only in younger patients, suggesting that non-medication approaches
with older adults may be more appropriate. A notable gap in the literature is the absence of
studies examining the use of antidepressant medication in conjunction with or in comparison
to other non-pharmaceutical, guideline-recommended66 depression therapies (e.g., CBT,
problem-solving therapy).
Other promising intervention approaches identified in the past five years via relatively
small pilot studies include supportive psychotherapy for adults with co-morbid
depression;67 intensive multi-therapy for improving QOL and self-care behavior;68
telemedicine support using short-messaging service (i.e., texting) for improving QOL;69 and
far-infrared sauna treatments for improving physical health, general health, social
functioning, stress, and fatigue.70 Larger, randomized trials of these approaches are
warranted. There has also been interest in the utility of yoga classes for improving QOL, but
one randomized trial found difficulties in implementing such classes and no impact on
QOL.71
There has been considerable interest in developing and evaluating approaches to support
healthy coping in the delivery of primary care; for example, collaborative care interventions
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for co-morbid depression in diabetes patients. Recent findings support the long-term
maintenance of effects of collaborative care on depression,72, 73 and its effectiveness when
applied to both younger and older patients,74 as well as in public safety-net clinics serving
primarily low-income, Hispanic adults with diabetes.75 Other research supports the utility of
the RADICAL model for eliminating rural-urban disparities in QOL among pediatric
diabetes patients, which implements a co-located team consisting of a pediatrician, diabetes
educator, and mental health nurse who meets regularly to discuss each patients’ care and
provide preference-matched therapy and emotional support to children and their families.76
Additional research has demonstrated the feasibility of employing pharmacy students in a
pharmacist-managed diabetes clinic to improve the identification of co-morbid depression in
diabetes patients.77 Thus, innovative care models which integrate mental health care into
traditional diabetes care settings appear to be a feasible and effective way of supporting
healthy coping across different patient populations.
Discussion, Conclusions, and Implications
Findings from studies published in the past five years, and particularly the recent
proliferation of articles examining psychosocial impacts of different diabetes treatments,
suggest growing appreciation within the medical and research communities of the complex
relationships between diabetes treatment, psychosocial factors, and metabolic control, and
the importance of explicitly considering quality of life impacts when treating diabetes
patients. The findings are also encouraging in that they suggest that there is much that
diabetes educators and other health care providers can do to improve coping, emotional
health, and QOL in their patients:
• Treatment intensification in response to poor metabolic control often improves both
clinical and quality-of-life outcomes.
• Type of diabetes treatment may have a large impact on QOL and other
psychosocial outcomes, suggesting that regimen changes in light of high levels of
distress and/or low health-related QOL should be considered and discussed with
patients. A wide range of instruments are available for assessing psychosocial and
QOL impacts of diabetes and its treatment, as described previously.1.
• Use of CSII in T1DM and other intensive therapies in diabetes generally, as well as
earlier initiation of insulin and/or minimizing complexity of OHA regimens in
T2DM diabetes specifically, can elicit improved emotional health and QOL.
• A variety of intervention approaches for enhancing healthy coping continue to
show positive results, providing educators and program planners an opportunity to
choose and implement options based on the needs and preferences of their patients
and available resources.
• With regard to the treatment of co-morbid depression, CBT and collaborative care
interventions have elicited some of the strongest supportive evidence for
effectiveness in real-world settings.
From these conclusions, a broad pattern emerges of considerable importance. It seems now
well established that, for a range of tactics and approaches to enhancing quality of diabetes
care, better control of diabetes leads to better quality of life. Given the normality of multiple
comorbidities in diabetes, clinicians may be hesitant to complicate regimens in a manner
that adds too great a burden on patients. Also, it has long been recognized that adherence is
compromised by complexity of treatment regimens.78 Nevertheless, it appears that
enhancing the intensity of treatment when glycemic control is poor is typically associated
not so much with greater experienced burden and distress but with feeling better.
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As the number and heterogeneity of medical treatments for controlling blood glucose in
diabetes continues to expand, there remains an ongoing need for research comparing the
effect of these different options on healthy coping outcomes. This research should examine
the possibility that psychosocial and quality of life impacts of different treatments may vary
across sub-populations, reflecting the different needs and unique circumstance of these
groups. For example, the impacts of treatment intensification on quality of life among older,
frail adults with multiple comorbidities may be very different than among those in their 40s
or 50s whose principal medical problem is diabetes. Thus, there is a need for additional
research comparing the effect of different diabetes treatment regimens on healthy coping
outcomes in the growing population of older, frail diabetes patients with multiple co-
morbidities. This is of critical importance given that in older, frail patients, given that
medication-related problems, adverse events, and risk of hypoglycemia are much more
common and minimizing treatment burden for patients and caregivers is of greater concern
compared to intense glycemic control.79-81
As noted above, a number of diverse intervention approaches to directly targeting coping
outcomes in diabetes patients have at least preliminary evidence supporting their efficacy
and/or effectiveness. The downside of these multiple options is that diabetes educators may
be uncertain as to which options may produce the best outcomes in their patient populations.
There is a need to conduct head-to-head comparisons of different approaches identified in
this review for directly targeting coping outcomes in diabetes with varying amounts of
evidence for efficacy and effectiveness. In addition, some approaches have very good
evidence in specific sub-populations (e.g., family therapy for youth with T1DM) but have
been virtually untested in other populations where they may be similar useful (e.g., older
patients with reduced functional independence). Future research should examine the
feasibility and effectiveness of adapting such approaches for use with a broader range of
patient populations.
Finally, there is a continued need1 for greater dissemination of approaches identified as
efficacious or effective in a particular setting. The greatest challenge remains how to
practically translate interventions into routine care so that more patients can benefit. More
research into large-scale dissemination methods as well as intervention toolkits and guides is
sorely needed. Among existing resources is “Healthy Coping in Diabetes: A Guide for
Program Development and Implementation82. It and other materials developed by the
Robert Wood Johnson Foundation’s Diabetes Initiative (http://diabetesnpo.im.wustl.edu/), as
well as professional and patient-education materials of the American Association of
Diabetes Educators and American Diabetes Association, may be especially helpful for those
in the field.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Outline of Search of Healthy Coping in Diabetes Management, 2006 to 2011
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Table 1
Domains of healthy coping
Domain Description
Depression Disorder of mood characterized by feelings of sadness or
emptiness, reduced interest in activities, sleep disturbances,
loss of energy, difficulty concentrating or making decisions83
Anxiety disorder Disorders characterized by abnormal or inappropriate
symptoms of anxiety (e.g., increased heart rate, tensed
muscles, intense worry), such as generalized anxiety
disorder or panic disorder83
Perceived stress Degree to which individuals perceived different aspects of
their lives as unpredictable, uncontrollable, and
overwhelming84
Diabetes-specific distress Negative emotional responses and perceived burden related
to diabetes85, 86
Positive attitudes and beliefs
about the illness and treatment
Psychological adjustment to diabetes;87 treatment
satisfaction;88
Positive relationships with others High perceptions of general and diabetes-specific social
support; family functioning
Health-related quality of life Subjective evaluation of overall physical, mental, and social
health and functioning
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Table 2
Key studies on the effects of treatment intensification with different types of therapies and
regimens in adults with type 2 diabetes
Reference Study Objectives andMethods Study Design Sample Size Findings
Best et al 2011(Best et
al., 2011)
Compare once-weekly
injections with exenatide to
two different classes of
OHAs (sitagliptin or
pioglitazone) with regard to










weekly plus placebo oral
capsule each morning,









health utility, and treatment
satisfaction were observed
for exenatide once-weekly







outcomes in type 2 diabetes






type 2 patients using insulin
glargine with or without
OHAs were randomized to
pramlintide or placebo
N = 211 Pramlintide use resulted in
decreases in total diabetesrelated
distress and
regimen-related distress in





Assess effect of adding
mealtime pramlintide or
rapid-acting insulin analog
RAIA) to basal insulin
therapy in patients with
uncontrolled type 2 diabetes
Open-label, randomized,
parallel group trial, stratified
with regard to use of basal
insulin prior to study
enrollment
N = 112 Adding either pramlintide or




distress and improved sleep





Bode et al 2010(Bode
et al., 2010)
Compare effect of adding a
GLP-1 once daily
medication (liraglutide)





trial; patients stratified by
initial treatment with a single
OHA vs. diet and exercise
only and randomized to
once-daily treatment with
once-daily liraglutide (GLP-
1) 1.2 mg or 1.8 mg or
glimepiride (sulfonylurea)




to glimepiride, with much
stronger effects at the higher





weight gain, tolerability, and
treatment satisfaction and
QOL for 3 different regimens
in insulin-naïve uncontrolled
type 2 diabetes patients: 1)
biphasic insulin aspart 30
alone, 2) biphasic insulin
aspart 30 + metformin, and




N = 308 The insulin regimens
improved QOL and
treatment satisfaction





Compare triple therapy with
OHA (metformin,
pioglitazone, and glyburide)
to twice-daily insulin plus
metformin in newly




N = 29 There were no group
differences in hypoglycemic
events, weight gain,
adherence, or changes in
QOL, and social worries
improved over time in both
groups. All patients assigned
to insulin reported
satisfaction with insulin
treatment and willingness to
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Reference Study Objectives andMethods Study Design Sample Size Findings





Assess effect of insulin
glargine (basal insulin)
initiation with no change in
OHA therapy versus
optimization of OHA therapy
on QOL
Randomized, controlled trial
of adults aged 18-80 with
type 2 diabetes and
inadequate glucose control
taking 0, 1, or two OHAs
N = 366 Addition of insulin glargine
versus more OHAs had
greater positive impact on
treatment satisfaction and
QOL.
Vinik et al 2007(Vinik
& Zhang, 2007)
Compare effect of add-on
insulin glargine versus
rosiglitazone on healthrelated
QOL in patients with
type 2 diabetes already





N = 217 Symptom distress, mood
symptoms, ophthalmologic
distress, fatigue distress,
and general self-rated health
improved more for the insulin
glargine group. Adverse
events were also less
frequent in the insulin
glargine group.
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Table 3
Summaries of Key Intervention Articles




Speight et al 2010(Speight et
al., 2010)
Evaluate long-term (44-month
follow-up) outcomes of Dose
Adjustment for Normal Eating
DAFNE), a structured
education
program in intensive insulin
therapy for adults with poorly
controlled type 1 diabetes
Observational cohort




versus after a 6-month
waitlist


















education program focused on
self-monitoring of blood
glucose in









Rossi et al 2010(Rossi et al.,
2010)
Compare use of a Diabetes







with type 1 diabetes were
randomly assigned to DID
versus carbohydrate
counting education






and duration of education
required was also lower.
Bendik et al 2009(Bendik et
al., 2009)
Evaluate training in flexible
insulin
therapy on psychological and
metabolic outcomes in type 1
diabetes patients; intervention
consisted of 7 weekly group
sessions
Pre-post within-group
comparison of type 1
diabetes patients















assigned to group or
individual DSME/T
N = 22 There was a non-significant
trend
for greater improvements in
empowerment, goal
attainment,
diet, and foot care for
Group




Lowe et al 2008(Lowe et al.,
2008)
Evaluate intensive insulin
management to help type 1
and
type 2 diabetes patients match




type 1 diabetes and type
2 diabetes assessed at 4-
monhts and 12-months




Nansel et al 2007(Nansel et
al., 2007)
Assess outcomes of a diabetes
self-management education







type 1 diabetes assigned
to personal trainer
intervention or usual care




on QOL or adherence.
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Reference Study Objectives andMethods Study Design
Sample
Size Findings










Americans with type 2
diabetes first participated












2009(Bastiaens et al., 2009)
Implement and evaluate a
group
self-management education
program in primary care for
adults
with type 2 diabetes
Pilot study; pre-post
within-group comparison
N = 44 Diabetes-related emotional










Evaluate a 16-week self-help












members, and improvement of
training skills for group
leaders as
well as group structure.
Multicenter randomized,
controlled trial; adult
patients at 7 health care
centers in Thailand
assigned to self-help
group program or control
group receiving diabetes
services






improved in the self-help
group



















trial; patients assigned to
RPS or NCM




RPS group compared to
NCM,













discussion of information and






N = 17 Improved some aspects of
wellbeing,
including feeling more
active and vigorous at
program
completion.
Problem-Solving and Coping Skills
Amoako et al 2008(Amoako
& Skelly, 2007;










American assigned to the
intervention or usual care





compared to usual care.
Gregg et al 2007(Gregg et al.,
2007)
Compare acceptance and
commitment therapy (ACT), a
coping skills intervention plus
diabetes education to diabetes
Randomized, controlled
trial; adults with type 2
diabetes assigned to ACT
plus education or
N = 81 After 3 months, the ACT
group
showed increased use of
acceptance and mindfulness
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Reference Study Objectives andMethods Study Design
Sample
Size Findings




acceptance coping and self-
care
mediated the effect of ACT
on
glycemic control.
Cognitive-Behavior Therapy (CBT) and Behavior Therapy
Van Bastelaar et al 2011
(van Bastelaar et al., 2011)
Evaluate a web-based CBT
intervention for adults with
type 1
or type 2 diabetes
Randomized controlled






















trial of adults with
inadequately controlled
diabetes
N = 344 There was no significant
effect of
either MET plus CBT or
MET




2010(Lehmkuhl et al., 2010)
Evaluate a Telehealth
Behavioral
Therapy (TBT) for youths
with





TBT or waitlist control
N = 32 Youth perception of
unsupportive behaviors
increased
and perception of caring
parental
behaviors decreased in the
TBT
vs. control group.
Amsberg et al 2009(Amsberg
et al., 2009)
Evaluate CBT intervention
delivered in a combined
group/individual format
Randomized controlled
trial; adults with poorly
controlled type 1 diabetes
assigned to intervention
or control group







Snoek et al 2008(Snoek et al.,
2008)
Compare CBT delivered in a
group format to blood-glucose
awareness training (BGAT) in
adults with poorly controlled
type
1 diabetes, and examine
whether
effects varied by baseline
depression
Randomized trial; adults
assigned to CBT or BGAT
N = 86 Both CBT and BGAT
improved
depressive symptoms at 12-
month follow-up.
Salamon et al 2010(Salamon
et al., 2010)
Evaluate a 1-hour CBT-based
intervention with 3 weekly
followup
phone calls in adolescents
with








N = 10 Pre-post differences in
diabetes-
related stress and concerns
about
self-care in social situations
were








2011(Monaghan et al., 2011)
Evaluate feasibility and initial
efficacy of a telephone






analyses were for prepost
changes in the 14
N = 14 Parenting stress and
perceived
social support improved for
parents after participating in
the










Thorpe et al. Page 21





for parents of young children
with
type 1 diabetes


















included in a previous
study




1/3 to 1/2 of a standard
deviation,
and general family conflict
decreased from 1/3 to 3/4 of
a
standard deviation.
Nansel et al 2009(Nansel et
al., 2009)








trial; families of children
with type 1 diabetes were
randomized to the family
problem-solving
intervention or usual care










was not powered for
outcome
analysis.
Ellis et al(D. Ellis et al.,
2008;
D. A. Ellis, Naar-King,
Templin, Frey, &
Cunningham, 2007;
D. A. Ellis, Templin, et al.,
2007;




MST) for adolescents with
poorly
controlled type 1 diabetes, and
examine family composition
(twoversus
one-parent families) as a
moderator of treatment effects
Randomized, controlled
trial; adolescents
assigned to MST or
control
N = 127 There was evidence for
improved
family relationships in two-
parent
families but not single-
parent
families.
Wysocki et al(Wysocki et al.,
2007;
Wysocki et al., 2006;
Wysocki et al., 2008)
Compare Behavioral Family
Systems Therapy (BFST)
intervention to an Educational




trial; families assigned to
BFST, ES, or usual care
N = 104 At treatment end, those
receiving
BFST had improved family
conflict
and adherence compared to
those receiving ES or usual
care,
with greater effects in
adolescents
with very poor initial
metabolic











2009(Echeverry et al., 2009)
Compare sertraline versus








N = 87 Depressive symptoms,
QOL, and
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Williams et al 2007(Williams
et al., 2007)
Examine effect of sertraline
maintenance therapy on time-
torecurrence
of major depressive














recurrence than placebo, but
there was no difference in





Beever et al 2010(Beever,
2010)
Evaluate effect of 3-times
weekly,
20-minute far-infrared sauna

















classes for adults with type 2
diabetes
Randomized trial; adults




minute yoga classes for
12 weeks or waitlist
control group
N = 59 The rate of ineligible
patients was
high, largely due to insulin
treatment or
contraindications to
yoga (e.g., ischemic heart
disease, cerebrovascular
disease), as was the rate of
refusal due to lack of
interest.












adult diabetes patients with
lower











N = 30 Symptoms of anxiety and
depression and diabetes-
related
distress decreased in the
intervention group, but not
the
control group.
Menard et al 2007(Menard et
al., 2007)




and group DSME/T, intensive
selfcare
regimens for SMBG, diet,
and exercise, 2 inter-visit
phone








trial; French adult patients
with poorly controlled type




















cellular phones and short




study; adults with type 1
diabetes on pump therapy
assigned to intervention
N = 30 QOL improved significantly
more
in the intervention group,
and
76% of patients felt that the
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Reference Study Objectives andMethods Study Design
Sample
Size Findings
texting) compared to usual
care in
adults with type 1 diabetes





Approaches in Primary Care




versus usual primary care in
older










consisting of choice of
first-line depression
therapy (psychotherapy,
















Katon et al 2008(Katon et al.,
2008)








trial at 9 HMO primary











care + stepped care as
needed
N = 329 There was a trend for
reduced 5-






The greatest cost reductions
were
seen in patients with most
severe
physical co-morbidity.










trial at 9 HMO primary











care + stepped care as
needed
N = 329 The Pathways intervention
increased days free from




Both contribute to an
estimated




Ell et al 2010(Ell, Katon, et
al., 2010)
Evaluate effectiveness of a
socioculturally
adapted collaborative
care intervention in 387
lowincome,
predominantly Hispanic
adults with diabetes and








care (initial choice of
problem-solving therapy
or medication or both,
plus stepped care as
needed) or enhanced
















Knight et al 2008(D. E.
Knight et al., 2008)
Evaluate feasibility of
screening
for depression and usefulness
of
this screening for identifying
undiagnosed and undertreated
depression using a student
Cross-sectional study;
patients attending a
diabetes care clinic were
screened for depression
by a student pharmacist
who then abstracted
additional information
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diabetes care clinic for
underserved, low-income,
inner
city adult diabetes patients
from their chart inadequately treated, and
48% of








model of rural pediatric
diabetes
care called RADICAL, which
involved a co-located team of
pediatrician, diabetes
educator,
and mental health nurse who




child and family emotional
support, and actively attempts
to




children under 21 years
old with type 1 diabetes








Jones et al 2006
(Jones, Turvey, Torner, &
Doebbeling, 2006)
Compare receipt of adequate
antidepressant dosing and
duration of therapy in veterans
with versus without diabetes
Retrospective cohort











but treatment duration often
fell
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